Palhano-Fontes F

Advanced Research Center with Psychedelics, Federal University of Rio Grande do Norte, Natal, RN, Brazil; Onofre Lopes University Hospital, Federal University of Rio Grande do Norte, Natal, RN, Brazil; Brain Institute, Federal University of Rio Grande do Norte, Natal, RN, Brazil.

36 papers · 7 preprints · ORCID

ArticleKetamine

Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy.

Varela YM, Cavalcanti-Ribeiro P, de Sousa GM +18

Europe PMC2026
ArticleKetamine

Dissociation and antidepressant response to subcutaneous esketamine: A clinical study.

Gonçalves KTDC, Tavares VDO, Palhano-Fontes F +12

Europe PMC2026
ArticleDMT

Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression.

Bolcont R, Palhano-Fontes F, Barros H +6

Europe PMC2026
PreprintKetamine

Preliminary Non-Randomized Clinical Trial of Subcutaneous Esketamine in Treatment-Resistant Depression: Exploring Adjunctive Effects of Ketamine-Assisted Psychotherapy

Varela YM, Cavalcanti-Ribeiro P, de Sousa GM +18

Europe PMC2026
PreprintDMT

DMT, Madness, and Healing: Psychosis Model, Therapy Model, and Their Relations to Mystical Experiences and Positive Emotionality

Wießner I, Falchi-Carvalho M, Laborde S +7

Europe PMC2026
ArticleDMT

Corrigendum to Safety, tolerability and subjective effects of vaporized N, N-Dimethyltryptamine: A randomized double-blind clinical trial [European Neuropsychopharmacology 97 (2025) 16-27].

Wießner I, Falchi-Carvalho M, Laborde S +18

Europe PMC2026
ArticlePsilocybin

An international mega-analysis of psychedelic drug effects on brain circuit function.

Girn M, Doss MK, Roseman L +24

Europe PMC2026
ArticlePsilocybin

Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.

Varela YM, de O Tavares VD, Delgado LM +12

Europe PMC2026
ArticleKetamine

N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine.

de Sousa-Silva AN, Moura CA, de Oliveira Torres CI +9

Europe PMC2026
ArticleKetamine

Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein.

Cavalcanti-Ribeiro P, De Souza LCAM, de Tavares VDO +11

Europe PMC2026
PreprintAyahuasca

Network Rerouting Under Ayahuasca: Temporally and Hemisphere-Resolved EEG Connectomics

Alves CL, Palhano-Fontes F, Toutain TGLdO +3

Europe PMC2025
ArticleAyahuasca

Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations.

Silva-Costa N, Pessoa JA, Andrade KC +4

Europe PMC2026
ArticleDMT

Expressive resource in a clinical psychedelic study: Art as an integration tool.

Barros H, Falchi-Carvalho M, Maia LO +5

Europe PMC2025
ArticleDMT

Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial.

Wießner I, Falchi-Carvalho M, Laborde S +18

Europe PMC2025
PreprintAyahuasca

Ayahuasca Shifts Brain Dynamics Toward Higher Entropy: Persistent Elevation of Ising Temperature Correlates with Acute Subjective Effects

Cabral-Carvalho RM, Palhano-Fontes F, Araujo DB +1

Europe PMC2025
ArticlePsilocybin

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.

Falchi-Carvalho M, Palhano-Fontes F, Wießner I +21

Europe PMC2025
ArticleAyahuasca

The Antidepressant Effects of Vaporized <i>N</i>,<i>N</i>-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression.

Falchi-Carvalho M, Barros H, Bolcont R +16

Europe PMC2025
ArticleKetamine

Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in Depression.

Tavares VDO, da Costa Gonçalves KT, de Morais Barros ML +10

Europe PMC2025
ArticleKetamine

Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices.

da Costa Gonçalves KT, de Tavares VDO, de Morais Barros ML +9

Europe PMC2025
ArticleKetamine

Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study.

Palhano-Fontes F, Cavalcanti-Ribeiro P, da Costa Gonçalves KT +13

Europe PMC2025
ArticleKetamine

Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression.

Lopes EITC, Cavalcanti-Ribeiro P, Palhano-Fontes F +7

Europe PMC2024
PreprintAyahuasca

The antidepressant effects of vaporized N,N-Dimethyltryptamine: a preliminary report in treatment-resistant depression

Falchi-Carvalho M, Barros H, Bolcont R +15

Europe PMC2024
ArticlePsilocybin

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.

Falchi-Carvalho M, Wießner I, Silva SRB +15

Europe PMC2024
ArticleAyahuasca

A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression.

Cruz L, Bienemann B, Palhano-Fontes F +3

Europe PMC2023
PreprintAyahuasca

A quantitative textual analysis of the subjective effects of ayahuasca in naive users with and without depression

Cruz L, Favero BB, Palhano-Fontes F +3

Europe PMC2023
ArticleLSD

LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals.

Wießner I, Falchi M, Daldegan-Bueno D +7

Europe PMC2023
ArticleAyahuasca

Moderators of ayahuasca's biological antidepressant action.

de Sousa GM, de Oliveira Tavares VD, de Menezes Galvão AC +10

Europe PMC2022
ArticleAyahuasca

Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior.

de Meiroz Grilo MLP, de Sousa GM, de Mendonça LAC +7

Europe PMC2022
ArticleLSD

Nootropic effects of LSD: Behavioral, molecular and computational evidence.

Ornelas IM, Cini FA, Wießner I +16

Europe PMC2022
ArticleLSD

LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility.

Wießner I, Olivieri R, Falchi M +6

Europe PMC2022
ArticleLSD

LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking.

Wießner I, Falchi M, Maia LO +10

Europe PMC2022
ArticleAyahuasca

Ayahuasca for the Treatment of Depression.

Palhano-Fontes F, Soares BL, Galvão-Coelho NL +2

Europe PMC2022
ArticleLSD

Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow.

Wießner I, Falchi M, Palhano-Fontes F +6

Europe PMC2022
ArticleLSD

LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.

Wießner I, Falchi M, Palhano-Fontes F +3

Europe PMC2023
ArticleAyahuasca

Subacute effects of the psychedelic ayahuasca on the salience and default mode networks.

Pasquini L, Palhano-Fontes F, Araujo DB

Europe PMC2020
ArticleAyahuasca

The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.

Zeifman RJ, Palhano-Fontes F, Hallak J +3

Europe PMC2019
PreprintAyahuasca

Subacute effects of the psychedelic ayahuasca on the salience and default mode networks

Pasquini L, Palhano-Fontes F, Araujo DB

Europe PMC2019
ArticleAyahuasca

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial.

de Almeida RN, Galvão ACM, da Silva FS +6

Europe PMC2019
ArticleAyahuasca

Characterizing Complex Networks Using Entropy-Degree Diagrams: Unveiling Changes in Functional Brain Connectivity Induced by Ayahuasca.

Viol A, Palhano-Fontes F, Onias H +3

Europe PMC2019
ArticleAyahuasca

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.

Palhano-Fontes F, Barreto D, Onias H +20

Europe PMC2019
ArticleAyahuasca

Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls.

Galvão ACM, de Almeida RN, Silva EADS +8

Europe PMC2018
ArticleAyahuasca

Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca.

Viol A, Palhano-Fontes F, Onias H +2

Europe PMC2017
ArticleAyahuasca

The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.

Palhano-Fontes F, Andrade KC, Tofoli LF +5

Europe PMC2015